Indaptus Therapeutics, Inc.
INDP
$2.44
$0.4220.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -19.75% | -38.79% | -13.25% | -7.71% | -5.15% |
| Total Depreciation and Amortization | -- | -- | -100.00% | -100.00% | -100.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 64.09% | 8.92% | -26.12% | -33.12% | -34.65% |
| Change in Net Operating Assets | -254.36% | 795.79% | -130.95% | -56.13% | 566.75% |
| Cash from Operations | -24.95% | -20.29% | -30.35% | -17.44% | -8.52% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -66.31% | 16.12% | 152.77% | 2,348.15% | 2,476.55% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 77.81% | 25.32% | -80.09% | -4,911.63% | -5,270.00% |
| Cash from Financing | 89.80% | 269.51% | 357.33% | 3,805.70% | 2,299.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 59.09% | 135.92% | 81.88% | 78.80% | -299.24% |